右美托咪定可以减轻大鼠脑缺血再灌注损伤

被引:3
作者
林玮
钱彬
林芩
机构
[1] 福建中医药大学附属人民医院麻醉科
关键词
α2肾上腺素能受体激动剂; 右美托咪定; 缺血再灌注损伤; 脑保护;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
目的:通过大鼠大脑缺血再损伤模型,评估右美托咪定的脑保护作用;并通过测定脑组织中TNF-α及ICAM-1含量的变化,推测右美托咪定可能的作用机制。方法:30只雄性清洁级成年SD大鼠,体重240~260g,采用线栓法建立大鼠大脑中动脉缺血再灌注损伤模型,阻断开始即匀速泵入药物,缺血2h后开放大脑中主动脉。根据处理方法的不同,随机分为3组:假手术组(n=6),对照组静脉注射生理盐水(n=6),实验组静脉注射右美托咪定1μg/kg(n=18)。实验组按再灌注时间分为3个亚组,即缺血2h后分别再灌注4、24、48h,每个亚组6只。记录再灌注后4、24、48h大鼠神经行为学评分,TTC染色法评估脑梗死体积,免疫组织化学方法检测脑组织TNF-α和ICAM-1的表达。结果:与对照组比较,右美托咪定组表现为动物神经行为学评分显著升高、大脑梗死体积减少,脑组织TNF-α和ICAM-1表达下降。结论:α2肾上腺素能受体激动剂(右美托咪定)对脑缺血再灌注损伤有保护作用;可以抑制TNF-α和ICAM-1的表达,推测α2肾上腺素能受体激动剂通过减少缺血再灌注过程中炎性因子的释放产生脑保护作用。
引用
收藏
页码:33 / 35
页数:3
相关论文
共 10 条
[1]
Role of Dexmedetomidine for the Prevention and Treatment of Delirium in Intensive Care Unit Patients [J].
Mo, Yoonsun ;
Zimmermann, Anthony E. .
ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) :869-876
[2]
The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage [J].
Cosar, Murat ;
Eser, Olcay ;
Fidan, Huseyin ;
Sahin, Onder ;
Buyukbas, Sadik ;
Ela, Yuksel ;
Yagmurca, Murat ;
Ozen, Oguz A. .
SURGICAL NEUROLOGY, 2009, 71 (01) :54-59
[3]
Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats [J].
Nakano, Takaaki ;
Okamoto, Hirotsugu .
JOURNAL OF ANESTHESIA, 2009, 23 (03) :378-384
[4]
Dexmedetomidine produces its neuroprotective effect via the α 2A -adrenoceptor subtype.[J].Daqing Ma;Mahmuda Hossain;Nishanthan Rajakumaraswamy;Mubarik Arshad;Robert D. Sanders;Nicholas P. Franks;Mervyn Maze.European Journal of Pharmacology.2004, 1
[5]
α 2 -Adrenoceptor agonists: shedding light on neuroprotection?.[J].Daqing Ma;Nishanthan Rajakumaraswamy;Mervyn Maze.British Medical Bulletin.2004,
[6]
Polymorphonuclear leukocyte activation induces cerebral hypoperfusion in rats in the absence of previous ischemia-reperfusion damage [J].
Chen, L ;
Vicaut, E ;
Sercombe, R .
NEUROSCIENCE LETTERS, 2002, 331 (03) :203-207
[7]
Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat [J].
Kostulas, N ;
Li, HL ;
Xiao, BG ;
Huang, YM ;
Kostulas, V ;
Link, H .
STROKE, 2002, 33 (04) :1129-1134
[8]
Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat [J].
Kuhmonen, J ;
Haapalinna, A ;
Sivenius, J .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (03) :261-271
[9]
Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia [J].
Jolkkonen, J ;
Puurunen, K ;
Koistinaho, J ;
Kauppinen, R ;
Haapalinna, A ;
Nieminen, L ;
Sivenius, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (01) :31-36
[10]
REVERSIBLE MIDDLE CEREBRAL-ARTERY OCCLUSION WITHOUT CRANIECTOMY IN RATS [J].
LONGA, EZ ;
WEINSTEIN, PR ;
CARLSON, S ;
CUMMINS, R .
STROKE, 1989, 20 (01) :84-91